Bank of America
DMRA

Bank of America’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Bank of America’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$405K Buy
15,647
+14,419
+1,174% +$371K ﹤0.01% 5009
2025
Q4 		$28.3K Sell
1,228
-5,272
-81% -$91.6K ﹤0.01% 5978
2025
Q3 		$24.2K Buy
6,500
+5,272
+429% +$17.9K ﹤0.01% 7035
2025
Q2 		$4.19K Buy
1,228
+2
+0.2% +$6 ﹤0.01% 7325
2025
Q1 		$3.8K Hold
1,226
– – ﹤0.01% 7258
2024
Q4 		$5.7K Buy
1,226
+1
+0.1% +$7 ﹤0.01% 7081
2024
Q3 		$14.9K Buy
1,225
+2
+0.2% +$26 ﹤0.01% 6805
2024
Q2 		$14.5K Buy
1,223
+7
+0.6% +$111 ﹤0.01% 6813
2024
Q1 		$23.7K Hold
1,216
– – ﹤0.01% 6721
2023
Q4 		$21.9K Sell
1,216
-104
-8% -$1.6K ﹤0.01% 6771
2023
Q3 		$23.7K Sell
1,320
-605
-31% -$23.8K ﹤0.01% 6681
2023
Q2 		$121K Sell
1,925
-166
-8% -$9.04K ﹤0.01% 6122
2023
Q1 		$104K Buy
2,091
+95
+5% +$5.01K ﹤0.01% 6242
2022
Q4 		$57.4K Buy
1,996
+122
+7% +$5.06K ﹤0.01% 6430
2022
Q3 		$89K Buy
1,874
+394
+27% +$20K ﹤0.01% 6397
2022
Q2 		$64K Buy
1,480
+27
+2% +$1.24K ﹤0.01% 6714
2022
Q1 		$80K Sell
1,453
-66
-4% -$3.71K ﹤0.01% 6972
2021
Q4 		$115K Buy
1,519
+20
+1% +$1.57K ﹤0.01% 6818
2021
Q3 		$135K Buy
1,499
+79
+6% +$8.45K ﹤0.01% 6548
2021
Q2 		$180K Buy
1,420
+1,222
+617% +$166K ﹤0.01% 6161
2021
Q1 		$30K Buy
198
+18
+10% +$4.9K ﹤0.01% 6780
2020
Q4 		$56K Buy
+180
New +$67K ﹤0.01% 6278

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Bank of America's DMRA Position: Q1 2026 in Review

Bank of America increased its Damora Therapeutics, Inc. Ordinary Shares (DMRA) stake by 1,174% in Q1 2026, buying an estimated $371K and bringing the position to 15,647 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #5009.

Bank of America first reported a position in DMRA in Q4 2020 and has held it in 22 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

  • Bank of America held 15,647 shares of Damora Therapeutics, Inc. Ordinary Shares worth $405K as of Q1 2026.
  • Bank of America bought 14,419 Damora Therapeutics, Inc. Ordinary Shares shares in Q1 2026, an estimated $371K.
  • Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5009 holding.
  • Bank of America first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q4 2020 and has held it in 22 quarters since.
  • 65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.